May 26, 2020
At a virtual May meeting, the University of Rochester Board of Trustees elected two new board members and recognized three individuals who become life trustees.
I am thrilled to welcome Betsy Ward and Martin Sanders to the board, said Board Chair Rich Handler 83. Its during an unprecedented time in the Universitys history that they are joining us, and their expertise and commitment to the University are needed now more than ever. I also want to express my gratitude to our new life trustees for their distinguished service over many years. We look forward to their continued engagement with the University.
University President Sarah Mangelsdorf said, I wish to welcome our newly elected members to the board and thank them in advance for their commitment. Im also very grateful to our newest life trustees, all of whom have made invaluable contributions to the University and provided wise counsel and support to me in my first year as president.
With current circumstances resulting from the COVID-19 pandemic, both new and life trustees will be recognized in person at a later date.
Martin Sanders is cofounder and CEO of Io Therapeutics, Inc., a privately held company based in Santa Ana, California, that develops treatments for Parkinsons disease, Alzheimers disease, multiple sclerosis, and various cancers. He is also the executive chairman of the companys board of directors.
Sanders, a medical doctor, has had a long career in clinical medicine, basic laboratory research in immunology, drug discovery research, pharmaceutical product development, patient care, venture capital investment, and serial company formation in the life sciences. He holds many patents, including one that was granted in March 2020 for treating nervous system disorders. Dedicated to bringing new treatments to people suffering from Parkinsons disease, cancer, migraines, and blindness, he has served as an advisor to more than 50 biopharmaceutical companies in the areas of preclinical and clinical product development since 1992.
Sanders is a passionate supporter of the arts and believes that art and music play a role in good health. In 2018, he and his wife, Corazon, established the Martin E. and Corazon D. Sanders Professorship in Voice at the Eastman School of Music in appreciation of their daughter, Lauras, voice teacher. Laura earned her bachelors degree in 2016 and a masters degree in 2018 in voice and opera from Eastman. Through the Sanderss generosity, Eastman celebrated the first installation of a performance faculty member into an endowed position. In addition, Martin Sanders is a member of the Eastman School of Music National Council and the University of Rochester Volunteer Task Force.
He received his medical degree from the University of Chicago; served as an intern and resident in internal medicine at Washington University Medical Center in St. Louis; and completed three postdoctoral fellowships in allergy/clinical immunology at the National Institute of Allergy and Infectious Diseases, in rheumatology at Johns Hopkins Medical School, and in cancer immunology at the immunology branch of the National Cancer Institute. He is board certified in internal medicine and in subspecialties allergy/clinical immunology and rheumatology.
Elizabeth (Betsy) Ward 86 is the chief financial officer at MassMutual, leading the finance department at the nearly 170-year-old life insurance company into a new era, with a focus on connecting finance to broader strategic planning. Before becoming CFO in 2016, she held several prominent positions at the Springfield, Massachusettsbased company, including chief enterprise risk officer and managing director at a couple of their subsidiary asset management firms.
Ward serves on the US Department of the Treasurys Federal Advisory Committee on Insurance and has been a member of the American Academy of Actuaries and the Fellow Society of Actuaries since the early 1990s. She has been a key contributor to global risk management through her work leading various industry groups. She has also served on federal committees on supervisory requirements and research, focusing on the effective groupwide supervision of insurance groups and seeking to narrow the gaps among global regulatory regimes.
Ward earned a bachelors degree in economics and Spanish from the University, while also studying flute through lessons at the Eastman School of Music. Music continues to play an important role in her life. She serves on the board of directors of the Community Music School of Springfield and continues to perform on flute in local classical ensembles, and as an alto singer with chamber choirs and chorales in Connecticut and Massachusetts.
In November 2019, Ward was the keynote speaker at the Universitys Simon Womens Conference. In 2012, she was named by Diversity Journal as a Woman Worth Watching in Financial Services, and in 2014, she was cited by Insurance Risk magazine as CRO of the Year.
At the May meeting, the board approved the transition of three individuals to life trustee status. Together the individuals have provided years of distinguished service to the board and their philanthropy has supported the creation of new facilities, scholarships, professorships, and other initiatives throughout the University.
Kathleen Murray 77 has been a board member since 2010, serving at different times on the Academic Affairs, Audit and Risk Assessment, Executive, Facilities, Human Resources, and Nominations and Board Practices committees. In her role as trustee, she has lent her business expertise to assist leadership in complex strategic, financial, and managerial issues, as well as supported key University goals through service on the Diversity Advisory Council, the NY Metro Women Steering Committee (for which she is chair emeritus), River Campus Libraries National Council, and Meliora Campaign Cabinet Chair.
In Arts, Sciences & Engineering, she established the Kathleen McMorran Murray 74 Endowed Scholarship Fund and Rochester Annual Fund. She has also exemplified generosity to other units of the University, particularly to the College Annual Fund, Diversity Program Fund, and the River Campus Libraries Annual Fund.
Francis Price 74, 75S (MBA) has provided business, financial and strategic advice to the University since he joined the Board in 1995. He has served on the Academic Affairs, Executive, Executive Alternate, Financial Planning (now Strategic and Financial Planning), Health Affairs, Nominations and Board Practices, and Student Affairs (now Student Life) committees during his tenure.
Price has additionally served on the Memorial Art Gallery Board of Managers, Diversity Initiative Campaign Committee; Hajim School of Engineering Visiting Committee; Los Angeles Regional Cabinet; and the Multicultural Alumni Advisory Council Executive Committee. In 2016, he volunteered his time to serve as the inaugural chair of the Public Safety Review Board.
He has generously supported the David T. Kearns Center, African-American Institute Gift Account, and the College Annual Fund.
E. Philip Saunders has provided distinguished service to the University as a member of the Board of Trustees since 2015. He has encouraged valuable discussions and principled engagement in a wide range of issues affecting the University. He has served with distinction on the Health Boards Affairs Committee, and served as Rochester Philanthropy Council chair; Medical Center Campaign Cabinet cochair; Medical Center Meliora Campaign vice-chair; and George Eastman Circle Rochester Leadership Council chair.
Saunders has provided extraordinary philanthropic support to the University. In 2011, he contributed $10 million to the University of Rochester Medical Center to support neuromuscular disease and translational research. The Saunders Research Building, home to the Clinical and Translational Science Institute, clinical research programs, and academic departments, was named in his honor. His gift also supports the Saunders Family Distinguished Professorship in Neuromuscular Research and the E. Philip and Carole Saunders Professorship in Neuromuscular Research. He served as a cochair of the Medical Centers campaign in support of The Meliora Challenge and honorary chair of the George Eastman Circle Rochester Leadership Council. He greatly influenced and encouraged philanthropy with the creation of the highly successful George Eastman Circle Plus One outreach concept, inspiring other units of the University to adopt the concept to increase engagement.
Tags: board of trustees
Category: University News
Link:
Board elects two members, honors three life trustees - University of Rochester
- Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off - R&D World - April 27th, 2025 [April 27th, 2025]
- Dr. Sabine Ehrt Named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine - WCM Newsroom - April 19th, 2025 [April 19th, 2025]
- RayThera launches with $110 million to advance immunology pipeline - The Pharma Letter - April 10th, 2025 [April 10th, 2025]
- Celebrate Vaccines: The legacy of the tetanus vaccine - British Society for Immunology - April 10th, 2025 [April 10th, 2025]
- Another immunology biotech emerges as Hillstar takes flight with $67M - Endpoints News - March 30th, 2025 [March 30th, 2025]
- Alumnus discovers passion for immunology, teaching at Mercer - Mercer University - March 15th, 2025 [March 15th, 2025]
- The future of immunology - Johnson & Johnson - March 5th, 2025 [March 5th, 2025]
- Immunotherapys Sweet Future: Wrapping up AACR IO 2025 With Glyco-immunology - American Association for Cancer Research (AACR) - March 5th, 2025 [March 5th, 2025]
- J&J receives three CHMP recommendations for immunology and oncology indications - PMLiVE - March 5th, 2025 [March 5th, 2025]
- Greater Austin Allergy, Asthma & Immunology now open in the Shops at the Galleria - Community Impact - March 5th, 2025 [March 5th, 2025]
- As dengue spreads, researchers discover a clue to fighting the virus - La Jolla Institute for Immunology - February 25th, 2025 [February 25th, 2025]
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business... - February 25th, 2025 [February 25th, 2025]
- PhD candidate Jesse Lehman receives Kirschstein Award to study immunology - UMass Medical School - February 25th, 2025 [February 25th, 2025]
- Cross-priming in cancer immunology and immunotherapy - Nature.com - February 3rd, 2025 [February 3rd, 2025]
- Sanofi Happy To Spend To Hit Immunology Top Spot - News & Insights - February 3rd, 2025 [February 3rd, 2025]
- The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- Immunology - The Scientist - January 23rd, 2025 [January 23rd, 2025]
- Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System - MedCity News - January 15th, 2025 [January 15th, 2025]
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]